These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

762 related items for PubMed ID: 12377952

  • 1. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
    Nagy ZS, Wang Y, Erwin-Cohen RA, Aradi J, Monia B, Wang LH, Stepkowski SM, Rui H, Kirken RA.
    J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway.
    Beadling C, Ng J, Babbage JW, Cantrell DA.
    EMBO J; 1996 Apr 15; 15(8):1902-13. PubMed ID: 8617237
    [Abstract] [Full Text] [Related]

  • 3. IL-2 and IL-7 induce heterodimerization of STAT5 isoforms in human peripheral blood T lymphoblasts.
    Rosenthal LA, Winestock KD, Finbloom DS.
    Cell Immunol; 1997 Nov 01; 181(2):172-81. PubMed ID: 9398404
    [Abstract] [Full Text] [Related]

  • 4. IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells.
    Rameil P, Lécine P, Ghysdael J, Gouilleux F, Kahn-Perlès B, Imbert J.
    Oncogene; 2000 Apr 20; 19(17):2086-97. PubMed ID: 10815800
    [Abstract] [Full Text] [Related]

  • 5. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH, Kirken RA, Erwin RA, Yu CR, Farrar WL.
    J Immunol; 1999 Apr 01; 162(7):3897-904. PubMed ID: 10201908
    [Abstract] [Full Text] [Related]

  • 6. IL-4 selectively inhibits IL-2-triggered Stat5 activation, but not proliferation, in human T cells.
    Castro A, Sengupta TK, Ruiz DC, Yang E, Ivashkiv LB.
    J Immunol; 1999 Feb 01; 162(3):1261-9. PubMed ID: 9973378
    [Abstract] [Full Text] [Related]

  • 7. Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of Stat5a and Ser730 of Stat5b in prolactin-sensitive cells.
    Yamashita H, Xu J, Erwin RA, Farrar WL, Kirken RA, Rui H.
    J Biol Chem; 1998 Nov 13; 273(46):30218-24. PubMed ID: 9804779
    [Abstract] [Full Text] [Related]

  • 8. Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.
    Kuroki M, O'Flaherty JT.
    Biochem J; 1999 Aug 01; 341 ( Pt 3)(Pt 3):691-6. PubMed ID: 10417333
    [Abstract] [Full Text] [Related]

  • 9. Regulation of IL-6 signaling by p53: STAT3- and STAT5-masking in p53-Val135-containing human hepatoma Hep3B cell lines.
    Rayanade RJ, Ndubuisi MI, Etlinger JD, Sehgal PB.
    J Immunol; 1998 Jul 01; 161(1):325-34. PubMed ID: 9647240
    [Abstract] [Full Text] [Related]

  • 10. Rapid activation of C-Raf-1 after stimulation of the T-cell receptor or the muscarinic receptor type 1 in resting T cells.
    Siegel JN, June CH, Yamada H, Rapp UR, Samelson LE.
    J Immunol; 1993 Oct 15; 151(8):4116-27. PubMed ID: 8409389
    [Abstract] [Full Text] [Related]

  • 11. Immunoreactivity of Stat5 phosphorylated on tyrosine as a cell-based measure of Bcr/Abl kinase activity.
    Jacobberger JW, Sramkoski RM, Frisa PS, Ye PP, Gottlieb MA, Hedley DW, Shankey TV, Smith BL, Paniagua M, Goolsby CL.
    Cytometry A; 2003 Aug 15; 54(2):75-88. PubMed ID: 12879454
    [Abstract] [Full Text] [Related]

  • 12. Cutting edge: TCR stimulation by antibody and bacterial superantigen induces Stat3 activation in human T cells.
    Gerwien J, Nielsen M, Labuda T, Nissen MH, Svejgaard A, Geisler C, Röpke C, Odum N.
    J Immunol; 1999 Aug 15; 163(4):1742-5. PubMed ID: 10438903
    [Abstract] [Full Text] [Related]

  • 13. Delineation and mapping of Stat5 isoforms activated by granulocyte colony-stimulating factor in myeloid cells.
    Chakraborty A, Dyer KF, Tweardy DJ.
    Blood Cells Mol Dis; 2000 Aug 15; 26(4):320-30. PubMed ID: 11042034
    [Abstract] [Full Text] [Related]

  • 14. Characterization of STAT5B phosphorylation correlating with expression of cytokine-inducible SH2-containing protein (CIS).
    Cooper JC, Boustead JN, Yu CL.
    Cell Signal; 2006 Jun 15; 18(6):851-60. PubMed ID: 16125365
    [Abstract] [Full Text] [Related]

  • 15. Interleukin 2 and 15 activate Stat3alpha in human T lymphocytes.
    Nielsen M, Nordahl M, Svejgaard A, Odum N.
    Cytokine; 1998 Oct 15; 10(10):735-8. PubMed ID: 9811525
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-9 (IL-9) induces cell growth arrest associated with sustained signal transducer and activator of transcription activation in lymphoma cells overexpressing the IL-9 receptor.
    Demoulin JB, Van Snick J, Renauld JC.
    Cell Growth Differ; 2001 Mar 15; 12(3):169-74. PubMed ID: 11306517
    [Abstract] [Full Text] [Related]

  • 17. IL-2-mediated cell cycle progression and inhibition of apoptosis does not require NF-kappa B or activating protein-1 activation in primary human T cells.
    Iacobelli M, Rohwer F, Shanahan P, Quiroz JA, McGuire KL.
    J Immunol; 1999 Mar 15; 162(6):3308-15. PubMed ID: 10092783
    [Abstract] [Full Text] [Related]

  • 18. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
    Kirken RA, Erwin RA, Wang L, Wang Y, Rui H, Farrar WL.
    J Immunol; 2000 Nov 01; 165(9):5097-104. PubMed ID: 11046040
    [Abstract] [Full Text] [Related]

  • 19. {beta}1 Integrin and IL-3R coordinately regulate STAT5 activation and anchorage-dependent proliferation.
    Defilippi P, Rosso A, Dentelli P, Calvi C, Garbarino G, Tarone G, Pegoraro L, Brizzi MF.
    J Cell Biol; 2005 Mar 28; 168(7):1099-108. PubMed ID: 15795318
    [Abstract] [Full Text] [Related]

  • 20. STAT5A interacts with and is phosphorylated upon activation of the mu-opioid receptor.
    Mazarakou G, Georgoussi Z.
    J Neurochem; 2005 May 28; 93(4):918-31. PubMed ID: 15857395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.